Gyre Therapeutics
GYRE
#6167
Rank
$0.64 B
Marketcap
$6.92
Share price
1.76%
Change (1 day)
-59.25%
Change (1 year)

Gyre Therapeutics (GYRE) - Cash on Hand

Cash on Hand as of December 2024 : $26.67 Million USD

According to Gyre Therapeutics's latest financial reports the company has $26.67 Million USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Gyre Therapeutics - Cash on Hand chart (from 2023 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31$26.67 M-20.41%
2023-12-31$33.5 M818.01%
2022-12-31$3.65 M-12.16%
2021-12-31$4.15 M